WestEnd Advisors’s Zimmer Biomet ZBH Stock Holding History

WestEnd Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$517	Hold	6	–	–	﹤0.01%	339
2026 Q1	$543	Hold	6	–	–	﹤0.01%	303
2025 Q4	$540	Hold	6	–	–	﹤0.01%	303
2025 Q3	$591	Sell	6 -3	-33%	-$297	﹤0.01%	290
2025 Q2	$821	Buy	9 +2	+29%	+$193	﹤0.01%	227
2025 Q1	$792	Buy	7 +4	+133%	+$428	﹤0.01%	230
2024 Q4	$317	Buy	3 +1	+50%	+$107	﹤0.01%	218
2024 Q3	$216	Sell	2 -1	-33%	-$109	﹤0.01%	285
2024 Q2	$326	Hold	3	–	–	﹤0.01%	199
2024 Q1	$396	Hold	3	–	–	﹤0.01%	174
2023 Q4	$365	Hold	3	–	–	﹤0.01%	180
2023 Q3	$337	Buy	+3	New	+$381	﹤0.01%	185
2023 Q1	–	Sell	-2	Closed	-$251	–	173
2022 Q4	$255	Sell	2 -1	-33%	-$116	﹤0.01%	201
2022 Q3	$0	Hold	3	–	–	﹤0.01%	341
2022 Q2	$315	Buy	+3	New	+$356	﹤0.01%	167
2022 Q1	–	Sell	-2	Closed	-$241	–	204
2021 Q4	$254	Buy	+2	New	+$262	﹤0.01%	232
2021 Q3	–	Hold	0	–	–	–	202
2021 Q2	–	Hold	0	–	–	–	191

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

WestEnd Advisors's ZBH Position: Q2 2026 in Review

WestEnd Advisors held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 6 shares worth $517. The position accounts for ﹤0.01% of the portfolio, ranked #339.

WestEnd Advisors first reported a position in ZBH in Q4 2021 and has held it in 16 quarters since. The position peaked at $821 in Q2 2025. 908 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

WestEnd Advisors held 6 shares of Zimmer Biomet worth $517 as of Q2 2026.
WestEnd Advisors left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #339 holding.
WestEnd Advisors first reported a position in Zimmer Biomet in Q4 2021 and has held it in 16 quarters since.
WestEnd Advisors's Zimmer Biomet position peaked at $821 in Q2 2025.
908 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.